Zacks Research Comments on Allstate FY2024 Earnings

The Allstate Co. (NYSE:ALL) – Equities researchers at Zacks Research issued their FY2024 earnings estimates for shares of Allstate in a research report issued on Wednesday, November 13th. Zacks Research analyst Z. Masood forecasts that the insurance provider will earn $15.42 per share for the year. The consensus estimate for Allstate’s current full-year earnings is $16.01 per share. Zacks Research also issued estimates for Allstate’s Q2 2025 earnings at $2.94 EPS, Q3 2025 earnings at $3.91 EPS, Q4 2025 earnings at $4.68 EPS, FY2025 earnings at $16.64 EPS, Q1 2026 earnings at $5.19 EPS and Q2 2026 earnings at $3.46 EPS.

Other research analysts also recently issued reports about the stock. StockNews.com downgraded shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. Evercore ISI upped their price objective on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. JPMorgan Chase & Co. lifted their target price on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. BMO Capital Markets boosted their price objective on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Finally, The Goldman Sachs Group upped their price target on Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $214.19.

Allstate Trading Down 1.7 %

ALL opened at $196.59 on Monday. The company has a market cap of $52.06 billion, a P/E ratio of 12.73, a PEG ratio of 1.76 and a beta of 0.48. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The company’s 50 day moving average is $190.50 and its 200-day moving average is $177.22. Allstate has a 1-year low of $132.74 and a 1-year high of $201.00.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter last year, the company posted $0.81 EPS. The company’s revenue for the quarter was up 14.7% compared to the same quarter last year.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.87%. Allstate’s dividend payout ratio is presently 23.83%.

Insider Activity

In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On Allstate

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Pathway Financial Advisers LLC grew its position in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after acquiring an additional 1,047,019 shares during the period. Allspring Global Investments Holdings LLC grew its stake in shares of Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after acquiring an additional 472,040 shares during the period. AQR Capital Management LLC raised its stake in Allstate by 181.6% in the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after acquiring an additional 464,337 shares during the period. TimesSquare Capital Management LLC purchased a new stake in Allstate during the third quarter valued at about $77,819,000. Finally, Acadian Asset Management LLC increased its stake in shares of Allstate by 3,839.0% in the second quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock worth $66,417,000 after purchasing an additional 405,553 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.